mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.8 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.8 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.0084 |
0.8 |